Review on bioavailability enhancement

  • Sheshgiri N. Gada Department of Pharmaceutics, Shri BSPM Pharmacy College, Ambajogai (M.S.), India
  • Mukesh K. Vaishnav Department of Pharmaceutics, Shri BSPM Pharmacy College, Ambajogai (M.S.), India
  • Mahesh J. Birajdar Department of Pharmaceutics, Shri BSPM Pharmacy College, Ambajogai (M.S.), India
  • Mahaveer K. Kabra Kota College of Pharmacy, Kota Rajasthan, India

Abstract

The U.S Food and Drug administration defines bioavailability as “The rate and extent to which the active drug ingredient or therapeutic moiety is absorbed from a drug product and become available at the site of drug action.” Many studies illustrate that difference in manufacturing procedures, as well as the composition of the dosage form; can affect the bioavailability of a drug product. The importance of bioavailability is related to the drug action. A pharmacological response occur when drug with receptor after administration. A pharmacological activity can only be observed above the minimum effective concentration, hence that concentration of the drug, which above MEC is required for drug. The solubility of poorly bioavailability drug can be enhanced by the pharmaceutical approach which involves modification of formulation, manufacturing process or the physico-chemical properties of the drug without changing the chemical structure or by the pharmacokinetic approach in which pharmacokinetic of the drug is altered or the biologic approach where the route of drug administration can be changed. The methods used for the enhancement of bioavailability are as follows: Particle size reduction, use of surfactants, use of salt forms, use of metastable polymorphs etc.

Keywords: Bioavailability, pharmacokinetic, pharmacodynamic

Downloads

Download data is not yet available.
Published
2012-07-25
Citations
How to Cite
Sheshgiri N. Gada, Mukesh K. Vaishnav, Mahesh J. Birajdar, & Mahaveer K. Kabra. (2012). Review on bioavailability enhancement. International Journal of Research in Pharmaceutical Sciences, 3(3), 426-431. Retrieved from https://pharmascope.org/index.php/ijrps/article/view/1058
Section
Review Articles
Article Level Metrix
Abstract Views: 5
PDF Downloaded: 13